Frankincense essential oil is known for its anti-inflammatory, antioxidant, and therapeutic properties. A recent study ...

FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 2Q25 ...

Cytora's proprietary oral mucosa stem cells treatment holds potential to be a game changer in the field of stem cell therapy YOK ...

Wound healing is not an easy process and is an interaction between many cell types, cytokines, mediators, and the vascular system. When an injury occurs, the first phase is always an outpouring of ...

Discover evidence-based strategies for healing diabetic wounds, from immediate care steps to advanced treatments, nutritional ...

Healing from past trauma helps parents become more present, less reactive, and more deeply connected to their children. Tools ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2. The ...

Once the CLEANVLU2 study is completed, a further Phase II study is planned over a longer period, with stratification for factors that may affect debridement and wound healing, before moving into ...

As CSO, Dr. Ilagan will continue to spearhead the advancement of cell-free biologic therapies from immunologically privileged tissues to regenerative medicine drugs for complex cutaneous ...

the company plans to conduct another Phase II trial over a longer time, which will include stratification for factors that may influence debridement as well as healing of the wound. This will ...

non-healing venous leg ulcers (VLUs). Interim results from part one of the study published in the International Wound Journal, highlights the investigational new drug’s potential as a first ...

BX211 was safe and well-toleratedBX211 produced sustained and statistically significant1 Percent Area Reduction (PAR) of ulcer size (p = 0.046 at ...